Release Date: 30/04/09 13:32 Summary: Quarterly Activities Report and Cash Flow Report to 31MAR09 Price Sensitive: Yes Download Document 729.71KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status